Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Market Cap	264.32B +22.8%
Revenue (ttm)	1.66T +1.1%
Net Income	20.97B -48.2%
EPS	521.09 -48.5%
Shares Out	36.66M
PE Ratio	13.84
Forward PE	n/a
Dividend	100.00 (1.32%)
Ex-Dividend Date	Mar 31, 2026

Volume	248,734
Open	7,210.00
Previous Close	7,210.00
Day's Range	6,990.00 - 7,270.00
52-Week Range	5,430.00 - 12,800.00
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1963
• Employees: 1,021
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 009290

Financial Performance

In 2025, Kwang Dong Pharmaceutical's revenue was 1.66 trillion, an increase of 1.15% compared to the previous year's 1.64 trillion. Earnings were 20.97 billion, a decrease of -48.20%.